title: The effects of hange-shashin-to on gastric function in comparison with sho-saiko-to.
abstract: The effects of "Hange-shashin-to (TJ-14)" on gastric function were examined in comparison with "Sho-saiko-to (TJ-9)". Oral treatment with TJ-14 (125-500 mg/kg) caused dose-dependent suppression of ethanol-induced gastric injury, while it did not suppress gastric lesions induced by water-immersion stress. TJ-9 (125-500 mg/kg, p.o.) suppressed both water-immersion stress-induced gastric lesions and ethanol-induced gastric injury in a dose-dependent manner. Intraduodenal administration of TJ-14 even at 500 mg/kg did not affect gastric juice secretion, while TJ-9 at 125 to 500 mg/kg dose-dependently suppressed gastric juice secretion. TJ-14 (125-500 mg/kg, p.o.) accelerated gastric emptying in normal rats and improved the delayed gastric emptying induced by BaCl2 in a dose-dependent manner, whereas such effect was not noted with TJ-9. Oral treatment with TJ-14 at 500 mg/kg significantly suppressed apomorphine-induced vomiting, but it did not affect copper sulfate-induced vomiting. These results suggest that TJ-14 exhibits an anti-ulcer action (probably based on its ability to protect the gastric mucosa), improvement of gastric emptying and an anti-emetic action. TJ-9 also showed anti-ulcer effects, probably based on its ability to suppress gastric secretion and to protect the gastric mucosa. Thus, the present study demonstrated the effectiveness of TJ-14 and TJ-9 against gastric disease, and provided basic data which explain the differences in clinical application between these two kampo medicines.
authors.affiliation: Central Research Laboratories, Tsumura & Co., Ibaraki, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kase
authors.forename: M
authors.initials: M
authors.lastname: Yuzurihara
authors.forename: S
authors.initials: S
authors.lastname: Iizuka
authors.forename: A
authors.initials: A
authors.lastname: Ishige
authors.forename: Y
authors.initials: Y
authors.lastname: Komatsu
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001058:Apomorphine / Q000009:adverse effects; D019327:Copper Sulfate / Q000009:adverse effects; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D000431:Ethanol / Q000633:toxicity; D005289:Ferrets; D005746:Gastric Emptying / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D008297:Male; D008516:Medicine, Chinese Traditional; D051381:Rats; D017208:Rats, Wistar; D013270:Stomach / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004365:Drugs, Chinese Herbal; C088236:hange-shashinto; D000431:Ethanol; C018142:saiko-keishi-to; D019327:Copper Sulfate; D001058:Apomorphine